endpoint Introduces IRT Mobile Platform for Clinical Trials

News provided by

endpoint

28 May, 2014, 14:00 BST

SAN FRANCISCO, May 28, 2014 /PRNewswire/ --

endpoint extends its PULSE™ platform to provide the IRT industry's most configurable mobile solution to date 

endpoint (May 28th 2014) has announced the delivery of its Interactive Response Technology (IRT) mobile offering, providing ready mobile access to a robust suite of customized endpoint study and supply management tools, real-time drill-down web reports, and patient management functionality via mobile devices.

The mobile solution is embedded in endpoint's proprietary PULSE™ configuration tool, enabling a single IRT system trial design configuration for all modalities, including; phone (IVR), web (IWR) and mobile (IMR). The optimized IMR interface permits sites and users to leverage 'anytime, anywhere' access to endpoint's IRT systems, allowing real-time decision making while on the go. The optimized interface supports extended IRT functionality, including the ability to record patient visits, manage study limits, modify supply strategies, review shipments, activate/deactivate sites, etc.

CEO and co-founder of endpoint Jon Dole commented "endpoint is giving the clinical trials industry the same user flexibility that people have become accustomed to in their daily lives. Given today's mobile lifestyle, our users expect access to real-time data, the ability to monitor and adjust critical study parameters, and access to IRT subject management modules via mobile devices. endpoint is staying ahead of the IRT curve and in-step with the latest technology with our mobile solution."

The mobile platform will be demonstrated at the annual Drug Information Association (DIA) conference from June 15-19thin San Diego, CA, where endpoint will be at Booth 2125. Clients can also learn more about endpoint's industry leading IRT solutions at http://www.endpointclinical.com.

Note to editors 

About endpoint  

Headquartered in San Francisco, CA, endpoint is the premier provider of interactive response technologies (IRT) systems and solutions for the clinical trials industry. endpoint's proprietary IRT system configuration engine PULSE ™ provides non-technical users with the necessary tools to design and deploy customized IRT solutions to meet the unique needs of any given clinical trial for randomization services and supply chain management.

For media enquiries, or if you wish to find out more about PULSE 3.0 and other endpoint services, please contact:

Ciaran Donnelly, Marketing    
Email: cdonnelly@endpointclinical.com 
Phone: +44-(0)777-2029-361
Website: http://www.endpointclinical.com

SOURCE endpoint